191 related articles for article (PubMed ID: 20696775)
1. Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome.
Chen YT; Nikulina K; Lazarev S; Bahrami AF; Noble LB; Gallup M; McNamara NA
Am J Pathol; 2010 Sep; 177(3):1333-43. PubMed ID: 20696775
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA
Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738
[TBL] [Abstract][Full Text] [Related]
3. Immune profile of squamous metaplasia development in autoimmune regulator-deficient dry eye.
Chen YT; Li S; Nikulina K; Porco T; Gallup M; McNamara N
Mol Vis; 2009; 15():563-76. PubMed ID: 19365590
[TBL] [Abstract][Full Text] [Related]
4. Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.
Li S; Nikulina K; DeVoss J; Wu AJ; Strauss EC; Anderson MS; McNamara NA
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):34-41. PubMed ID: 18172072
[TBL] [Abstract][Full Text] [Related]
5. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
[TBL] [Abstract][Full Text] [Related]
6. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.
Zhou D; Chen YT; Chen F; Gallup M; Vijmasi T; Bahrami AF; Noble LB; van Rooijen N; McNamara NA
Am J Pathol; 2012 Sep; 181(3):753-60. PubMed ID: 22770665
[TBL] [Abstract][Full Text] [Related]
7. Establishing PAX6 as a biomarker to detect early loss of ocular phenotype in human patients with Sjögren's syndrome.
McNamara NA; Gallup M; Porco TC
Invest Ophthalmol Vis Sci; 2014 Sep; 55(11):7079-84. PubMed ID: 25228544
[TBL] [Abstract][Full Text] [Related]
8. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
9. Mouse Models of Sjögren's Syndrome with Ocular Surface Disease.
Masli S; Dartt DA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266081
[TBL] [Abstract][Full Text] [Related]
10. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation.
Pflugfelder SC; Tseng SC; Yoshino K; Monroy D; Felix C; Reis BL
Ophthalmology; 1997 Feb; 104(2):223-35. PubMed ID: 9052626
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
12. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
[TBL] [Abstract][Full Text] [Related]
13. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium.
Jones DT; Monroy D; Ji Z; Atherton SS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3493-504. PubMed ID: 8056525
[TBL] [Abstract][Full Text] [Related]
15. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
17. Alterations of ocular surface gene expression in Sjögren's syndrome.
Jones DT; Monroy D; Ji Z; Pflugfelder SC
Adv Exp Med Biol; 1998; 438():533-6. PubMed ID: 9634933
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
[TBL] [Abstract][Full Text] [Related]
19. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
20. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
